These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 11171285

  • 1. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
    Böger RH, Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG.
    Clin Sci (Lond); 2001 Feb; 100(2):161-7. PubMed ID: 11171285
    [Abstract] [Full Text] [Related]

  • 2. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
    Böger RH, Bode-Böger SM, Sydow K, Heistad DD, Lentz SR.
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
    [Abstract] [Full Text] [Related]

  • 3. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid.
    Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T.
    Clin Sci (Lond); 1999 Mar; 96(3):235-9. PubMed ID: 10029559
    [Abstract] [Full Text] [Related]

  • 4. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
    Stühlinger MC, Oka RK, Graf EE, Schmölzer I, Upson BM, Kapoor O, Szuba A, Malinow MR, Wascher TC, Pachinger O, Cooke JP.
    Circulation; 2003 Aug 26; 108(8):933-8. PubMed ID: 12912818
    [Abstract] [Full Text] [Related]

  • 5. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC, Stanger O.
    Curr Drug Metab; 2005 Feb 26; 6(1):3-14. PubMed ID: 15720202
    [Abstract] [Full Text] [Related]

  • 6. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
    Sydow K, Böger RH.
    Z Kardiol; 2001 Jan 26; 90(1):1-11. PubMed ID: 11220081
    [Abstract] [Full Text] [Related]

  • 7. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
    Sydow K, Schwedhelm E, Arakawa N, Bode-Böger SM, Tsikas D, Hornig B, Frölich JC, Böger RH.
    Cardiovasc Res; 2003 Jan 26; 57(1):244-52. PubMed ID: 12504835
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K, Hornig B, Arakawa N, Bode-Böger SM, Tsikas D, Münzel T, Böger RH.
    Vasc Med; 2004 May 26; 9(2):93-101. PubMed ID: 15521698
    [Abstract] [Full Text] [Related]

  • 15. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE, Boucher ML, Silver AE, Monahan KD, Seals DR.
    J Appl Physiol (1985); 2007 Jan 26; 102(1):63-71. PubMed ID: 16946027
    [Abstract] [Full Text] [Related]

  • 16. Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocystinemia in humans: effect of oxidative stress and proinflammatory cytokines.
    Antoniades C, Tousoulis D, Marinou K, Vasiliadou C, Tentolouris C, Bouras G, Pitsavos C, Stefanadis C.
    Am J Clin Nutr; 2006 Oct 26; 84(4):781-8. PubMed ID: 17023704
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients.
    Ducloux D, Ruedin C, Gibey R, Vautrin P, Bresson-Vautrin C, Rebibou JM, Chalopin JM.
    Nephrol Dial Transplant; 1998 Nov 26; 13(11):2890-3. PubMed ID: 9829496
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.